Trial ID or NCT#



not recruiting iconNOT RECRUITING


The purpose of this study is to develop and validate endpoint measures that can accurately determine whether patients are responding to treatment for chronic Graft-versus-Host Disease (GVHD). Hopefully, this will also lead to being better able to predict which patients will respond to what therapies.

Official Title

Chronic GVHD Response Measures Validation

Eligibility Criteria

Ages Eligible for Study: 7 Years to 99 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


Sally Arai
Sally Arai
Blood and marrow transplant specialist, Hematologist, Blood and marrow transplant specialist
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

Contact us to find out if this trial is right for you.


Physician Referrals
(650) 723-0822